Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study.
fluorescence in situ hybridization
immunohistochemistry
next generation sequencing
oncocytic tumors
papillary tumors
renal cell tumors
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
28 Jan 2021
28 Jan 2021
Historique:
received:
13
12
2020
revised:
11
01
2021
accepted:
24
01
2021
entrez:
2
2
2021
pubmed:
3
2
2021
medline:
3
2
2021
Statut:
epublish
Résumé
The occurrence of kidney oncocytic lesions with an admixed papillary component is not unusual in routine pathology practice. These neoplasms with dual morphology are classically recognized as collision tumors with variable malignant potential. Using immunohistochemistry, we investigated fluorescent in situ hybridization and next generation sequencing of the genetic and phenotypic profiles in the two components of 11 kidney tumors with colliding oncocytic and papillary features. The oncocytic component was CD117 positive, CK7 negative, and AMACR negative; the papillary component was CK7 positive, AMACR positive, and CD117 negative in all cases. Fluorescence in situ hybridization (FISH) results were inconsistent. Next generation sequencing (NGS) analysis demonstrated that the mutations identified in the two tumor components were identical and displayed an allelic frequency of approximately 50%, strongly suspicious for genetic polymorphisms. The two oncocytic and papillary tumor counterparts shared the same genetic profile and did not harbor pathogenic mutations. Clinical confirmation of the biological benign features of these tumors is required. The term collision tumor is not suitable for these neoplasms, and we propose the term oncopapillary tumor for this histological entity.
Identifiants
pubmed: 33525402
pii: diagnostics11020184
doi: 10.3390/diagnostics11020184
pmc: PMC7910958
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Roberto and Cornelia Pallotti's Legacy for Cancer Research
ID : to M.F.
Références
Case Rep Pathol. 2016;2016:2605045
pubmed: 27807494
Am J Surg Pathol. 2013 Oct;37(10):1469-89
pubmed: 24025519
Am J Surg Pathol. 2014 Aug;38(8):e35-49
pubmed: 25025368
Diagnostics (Basel). 2020 Feb 23;10(2):
pubmed: 32102250
Am J Clin Pathol. 2015 Nov;144(5):811-6
pubmed: 26486747
Virchows Arch. 2020 Mar;476(3):399-407
pubmed: 31444626
Can Urol Assoc J. 2014 Jul;8(7-8):E536-9
pubmed: 25210558
Mod Pathol. 2003 Oct;16(10):1060-3
pubmed: 14559991
Dermatol Ther. 2020 Nov;33(6):e14236
pubmed: 32852089
Ann Diagn Pathol. 2017 Aug;29:32-36
pubmed: 28807339
Pathol Int. 2018 Jul;68(7):431-435
pubmed: 29770587
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Pathology. 2016 Jan;48(1):41-6
pubmed: 27020208
Recent Pat Anticancer Drug Discov. 2018;13(1):118-124
pubmed: 29090670
Pathol Res Pract. 2014 Apr;210(4):217-23
pubmed: 24447800
Mod Pathol. 1997 Nov;10(11):1143-50
pubmed: 9388066